Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Hughes R, Dalakas MC, Merkies I, Latov N, L├ęger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP; FORCIDP Trial Investigators.

Lancet Neurol. 2018 Aug;17(8):689-698. doi: 10.1016/S1474-4422(18)30202-3. Epub 2018 Jul 9. Erratum in: Lancet Neurol. 2018 Nov;17(11):933.

2.

Measuring disease activity and clinical response during maintenance therapy in CIDP: from ICE trial outcome measures to future clinical biomarkers.

Katzberg HD, Latov N, Walker FO.

Neurodegener Dis Manag. 2017 Apr;7(2):147-156. doi: 10.2217/nmt-2016-0058. Epub 2017 Jan 23. Review.

3.

Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.

Vo ML, Chin RL, Miranda C, Latov N.

Muscle Nerve. 2017 Oct;56(4):732-736. doi: 10.1002/mus.25553. Epub 2017 Mar 24.

PMID:
28085193
4.

Abnormal Nutritional Factors in Patients Evaluated at a Neuropathy Center.

Latov N, Vo ML, Chin RL, Carey BT, Langsdorf JA, Feuer NT.

J Clin Neuromuscul Dis. 2016 Jun;17(4):212-4. doi: 10.1097/CND.0000000000000128.

PMID:
27224436
5.
6.

Maintenace therapy in chronic inflammatory demyelinating polyradiculoneuropathy.

Latov N, Chin RL, Vo ML.

Muscle Nerve. 2015 Nov;52(5):915. doi: 10.1002/mus.24743. Epub 2015 Aug 8. No abstract available.

PMID:
26088325
7.

Elevated blood mercury levels in idiopathic axonal neuropathy.

Latov N, Kumar G, Vo ML, Chin RL, Carey BT, Langsdorf JA, Feuer NT.

JAMA Neurol. 2015 Apr;72(4):474-5. doi: 10.1001/jamaneurol.2015.1. No abstract available.

PMID:
25867721
8.

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Chin RL, Deng C, Bril V, Hartung HP, Merkies IS, Donofrio PD, Van Doorn PA, Dalakas MC, Latov N.

Muscle Nerve. 2015 Oct;52(4):498-502. doi: 10.1002/mus.24624. Epub 2015 Jul 24.

PMID:
25728021
9.

Reply: Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of CIDP.

Vo ML, Hanineva A, Chin RL, Carey BT, Latov N, Langsdorf JA.

Muscle Nerve. 2015 Jan;51(1):148-9. doi: 10.1002/mus.24479. Epub 2014 Nov 20. No abstract available.

PMID:
25287579
10.

Unreliability of commercial anti-MAG antibody and ganglioside assays.

Vo ML, Latov N.

Muscle Nerve. 2015 Mar;51(3):458-9. doi: 10.1002/mus.24456. Epub 2015 Jan 9. No abstract available.

PMID:
25211153
11.

Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.

Vo ML, Hanineva A, Chin RL, Carey BT, Latov N, Langsdorf JA.

Muscle Nerve. 2015 Apr;51(4):549-53. doi: 10.1002/mus.24424. Epub 2015 Feb 17.

PMID:
25131219
12.

Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Latov N.

Nat Rev Neurol. 2014 Aug;10(8):435-46. doi: 10.1038/nrneurol.2014.117. Epub 2014 Jul 1. Review.

PMID:
24980070
13.

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study.

Vanhoutte EK, Latov N, Deng C, Hanna K, Hughes RA, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS.

Eur J Neurol. 2013 May;20(5):748-55. doi: 10.1111/j.1468-1331.2012.03851.x. Epub 2012 Aug 14.

PMID:
22891893
14.

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.

Chandra A, Latov N, Wormser GP, Marques AR, Alaedini A.

Clin Immunol. 2011 Oct;141(1):103-10. doi: 10.1016/j.clim.2011.06.005. Epub 2011 Jul 2.

15.

Prolongation of the tibialis anterior CMAP duration in chronic inflammatory demyelinating polyneuropathy.

Nodera H, Latov N, Carey B, Langsdorf J, Bedoya V, Tacheva S, Chin RL.

Clin Neurophysiol. 2012 Feb;123(2):393-8. doi: 10.1016/j.clinph.2011.05.031. Epub 2011 Jul 20.

PMID:
21767985
16.

Biomarkers of CIDP in patients with diabetes or CMT1.

Latov N.

J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:14-7. doi: 10.1111/j.1529-8027.2011.00299.x.

PMID:
21696491
17.

Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece.

Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV.

J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:1-2. doi: 10.1111/j.1529-8027.2011.00297.x. No abstract available.

PMID:
21696489
18.

Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.

Chandra A, Wormser GP, Marques AR, Latov N, Alaedini A.

Clin Vaccine Immunol. 2011 May;18(5):767-71. doi: 10.1128/CVI.00002-11. Epub 2011 Mar 16.

19.

Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.

Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C; ICE Study Group.

J Peripher Nerv Syst. 2010 Sep;15(3):208-15. doi: 10.1111/j.1529-8027.2010.00274.x.

PMID:
21040143
20.

Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.

Donofrio PD, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes R, Latov N, Merkies I, van Doorn P; IGIV-C CIDP Efficacy (ICE) Study Group.

Arch Neurol. 2010 Sep;67(9):1082-8. doi: 10.1001/archneurol.2010.223. Erratum in: Arch Neurol. 2010 Dec; 67(12):1515.

PMID:
20837852
21.

Electrophysiologic correlations with clinical outcomes in CIDP.

Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Katzberg H, Latov N, Merkies IS, Van Doorn PA; ICE Study Group.

Muscle Nerve. 2010 Oct;42(4):492-7. doi: 10.1002/mus.21733.

PMID:
20665514
22.

Gene expression profiling in nerve biopsy of vasculitic neuropathy.

Kinter J, Broglio L, Steck AJ, Tolnay M, Fuhr P, Latov N, Kalbermatten D, Sinnreich M, Schaeren-Wiemers N, Renaud S.

J Neuroimmunol. 2010 Aug 25;225(1-2):184-9. doi: 10.1016/j.jneuroim.2010.05.023. Epub 2010 Jun 12.

PMID:
20542337
23.

Demyelinating neuropathy in patients with hepatitis C virus infection.

Chin RL, Sander HW, Brannagan TH 3rd, De Sousa E, Latov N.

J Clin Neuromuscul Dis. 2010 Jun;11(4):209-12. doi: 10.1097/CND.0b013e3181b701c1.

PMID:
20516810
24.

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA; IGIV-C CIDP Efficacy (ICE) Study Group.

Arch Neurol. 2010 Jul;67(7):802-7. doi: 10.1001/archneurol.2010.105. Epub 2010 May 10.

PMID:
20457948
25.

Have we finally identified an autoimmune demyelinating disease?

Steck A, Latov N.

Ann Neurol. 2010 Apr;67(4):552; author reply 552-3. doi: 10.1002/ana.21990. No abstract available.

PMID:
20437595
26.

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A.

Brain Behav Immun. 2010 Aug;24(6):1018-24. doi: 10.1016/j.bbi.2010.03.002. Epub 2010 Mar 18.

27.

Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.

Lee G, Xiang Z, Brannagan TH 3rd, Chin RL, Latov N.

J Neurol Sci. 2010 Mar 15;290(1-2):115-22. doi: 10.1016/j.jns.2009.10.006. Epub 2009 Nov 17.

PMID:
19922956
28.

Clinical applications of intravenous immunoglobulins in neurology.

Hughes RA, Dalakas MC, Cornblath DR, Latov N, Weksler ME, Relkin N.

Clin Exp Immunol. 2009 Dec;158 Suppl 1:34-42. doi: 10.1111/j.1365-2249.2009.04025.x. Review.

29.

Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.

Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, Latov N, Quick A, Tandan R.

Muscle Nerve. 2009 Nov;40(5):890-900. doi: 10.1002/mus.21433. Review.

PMID:
19768755
30.

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

PM R. 2009 Jan;1(1):14-22. doi: 10.1016/j.pmrj.2008.11.011. Review.

PMID:
19627868
31.

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

PM R. 2009 Jan;1(1):5-13. doi: 10.1016/j.pmrj.2008.11.010. Review.

PMID:
19627867
32.

Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.

De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH 3rd.

J Clin Neuromuscul Dis. 2009 Jun;10(4):163-9. doi: 10.1097/CND.0b013e31819a71e1.

PMID:
19494726
33.

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.

Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA; ICE Study Group.

Neurology. 2009 Apr 14;72(15):1337-44. doi: 10.1212/WNL.0b013e3181a0fd80.

PMID:
19365055
34.

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.

Bril V, Katzberg H, Donofrio P, Banach M, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes RA, Latov N, Merkies IS, van Doorn PA; ICE Study Group.

Muscle Nerve. 2009 Apr;39(4):448-55. doi: 10.1002/mus.21236.

PMID:
19260050
35.

Specific electron transport chain abnormalities in amyotrophic lateral sclerosis.

Lin J, Diamanduros A, Chowdhury SA, Scelsa S, Latov N, Sadiq SA.

J Neurol. 2009 May;256(5):774-82. doi: 10.1007/s00415-009-5015-8. Epub 2009 Feb 25.

PMID:
19240958
36.

Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review).

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

Muscle Nerve. 2009 Jan;39(1):106-15. doi: 10.1002/mus.21227. Review.

PMID:
19086069
37.

Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review).

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

Muscle Nerve. 2009 Jan;39(1):116-25. doi: 10.1002/mus.21226. Review.

PMID:
19086068
38.

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology.

Neurology. 2009 Jan 13;72(2):177-84. doi: 10.1212/01.wnl.0000336345.70511.0f. Epub 2008 Dec 3. Review.

39.

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology.

Neurology. 2009 Jan 13;72(2):185-92. doi: 10.1212/01.wnl.0000336370.51010.a1. Epub 2008 Dec 3. Review.

PMID:
19056666
40.

Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease.

Souayah N, Chin RL, Brannagan TH, Latov N, Green PH, Kokoszka A, Sander HW.

Eur J Neurol. 2008 Dec;15(12):1300-3. doi: 10.1111/j.1468-1331.2008.02305.x.

PMID:
19049545
41.

Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment.

Alaedini A, Xiang Z, Kim H, Sung YJ, Latov N.

Exp Neurol. 2008 Apr;210(2):368-74. doi: 10.1016/j.expneurol.2007.11.018. Epub 2007 Dec 3.

PMID:
18191839
42.

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.

Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group.

Lancet Neurol. 2008 Feb;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0. Erratum in: Lancet Neurol. 2008 Sep;7(9):771.

PMID:
18178525
43.

Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, Sander HW, Green PH, Hallett M, Latov N.

J Immunol. 2007 May 15;178(10):6590-5.

44.

Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion.

Gondim FA, De Sousa EA, Latov N, Sander HW, Chin RL, Brannagan TH.

J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):902-4. Epub 2007 Mar 12.

45.

Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology.

Goldfarb AR, Latov N, Brannagan TH 3rd, Chin RL, de Sousa EA, Sander HW.

Neurol Neurophysiol Neurosci. 2006 Dec 22:7.

PMID:
17260084
46.

Multifocal axonal polyneuropathy in celiac disease.

Chin RL, Tseng VG, Green PH, Sander HW, Brannagan TH 3rd, Latov N.

Neurology. 2006 Jun 27;66(12):1923-5.

PMID:
16801661
47.
48.
49.

Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

Latov N, Gorson KC, Brannagan TH 3rd, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM.

J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57.

PMID:
19078800
50.

Altered subicular MAP2 immunoreactivity in schizophrenia.

Rosoklija G, Keilp JG, Toomayan G, Mancevski B, Haroutunian V, Liu D, Malespina D, Hays AP, Sadiq S, Latov N, Dwork AJ.

Prilozi. 2005 Dec;26(2):13-34.

PMID:
16400226

Supplemental Content

Support Center